MetLife Investment Management’s CIMAREX ENERGY CO XEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-49,392
Closed -$4.31M 2620
2021
Q3
$4.31M Sell
49,392
-1,987
-4% -$138K 0.04% 450
2021
Q2
$3.72M Sell
51,379
-1,725
-3% -$117K 0.03% 547
2021
Q1
$3.15M Sell
53,104
-2,691
-5% -$144K 0.03% 645
2020
Q4
$2.09M Sell
55,795
-2,631
-5% -$84.2K 0.02% 803
2020
Q3
$1.42M Sell
58,426
-2,207
-4% -$58.1K 0.02% 872
2020
Q2
$1.67M Buy
60,633
+2,193
+4% +$54.4K 0.02% 802
2020
Q1
$984K Buy
58,440
+31,395
+116% +$1.13M 0.01% 908
2019
Q4
$1.42M Sell
27,045
-565
-2% -$26.3K 0.01% 942
2019
Q3
$1.32M Sell
27,610
-348
-1% -$16.5K 0.01% 939
2019
Q2
$1.66M Sell
27,958
-878
-3% -$56.1K 0.02% 891
2019
Q1
$2.02M Buy
28,836
+1,494
+5% +$107K 0.02% 818
2018
Q4
$1.69M Sell
27,342
-395
-1% -$32.4K 0.02% 825
2018
Q3
$2.58M Sell
27,737
-355
-1% -$32.6K 0.03% 750
2018
Q2
$2.86M Sell
28,092
-629
-2% -$59.7K 0.03% 647
2018
Q1
$2.69M Sell
28,721
-753
-3% -$80.2K 0.03% 663
2017
Q4
$3.6M Buy
+29,474
New +$3.44M 0.04% 528

MetLife Investment Management's XEC Position: Q4 2021 in Review

MetLife Investment Management sold out of CIMAREX ENERGY CO (XEC) in Q4 2021, closing a stake of 49,392 shares — an estimated $4.31M sold.

MetLife Investment Management first reported a position in XEC in Q4 2017 and held it in 16 quarters. The position peaked at $4.31M in Q3 2021. 1 fund tracked by Wall St. Rank holds XEC as of Q4 2021.

  • MetLife Investment Management reported no remaining CIMAREX ENERGY CO position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 49,392 CIMAREX ENERGY CO shares in Q4 2021, an estimated $4.31M.
  • MetLife Investment Management first reported a position in CIMAREX ENERGY CO in Q4 2017 and held it in 16 quarters.
  • MetLife Investment Management's CIMAREX ENERGY CO position peaked at $4.31M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held CIMAREX ENERGY CO as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.